Hasten Biopharmaceutic’s $322 Million Acquisition of Takeda’s Portfolio

White & Case LLP has advised Takeda Pharmaceutical Company Limited on the deal. Takeda Pharmaceutical Company Limited (Takeda) signed an agreement to divest a portfolio of…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Paolo Bossi

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here